| 
 |  
 
 
 | 
 
 
 |  
	Search
 
 
 
12/19/2016     Robert Kornfeld, DPM
  
Nutraceuticals and Diabetes (Paul Kesselman, DPM
  
Here we go again. It is truly maddening to me  that the "evidence" the status quo is still  looking for are the effects of a drug vs. a  placebo. And now, we are substituting nutrients  and measuring their effects as if they are  drugs. I opine that the entire evidence-based  model fails miserably in its understanding of  what we should be measuring. I've said this  before and I'll say it again, all of these  studies conveniently ignore the patient and  their unique physiology, genetics, and  epigenetics. If you are going to use  nutraceuticals in the treatment of diabetic  neuropathy, then there must be a deeply layered  protocol put into action prior to the  prescription of nutraceuticals. 
  We first need to educate the patient, optimize  the epigenetic influence (a healthy patient-  specific diet, exercise, stress control, sleep  hygiene, hydration, communication skills, etc.)  and work to facilitate salutogenesis (a  movement toward efficient homeostasis). It  starts with a systems analysis. You need to  consider the fact that microangiopathy  restricts the delivery of nutrients and oxygen  to the involved limb. So what are we comparing  in a population of diabetics who are all at  different stages of pathology when we give them  a "pill" and disqualify nutrients as medicinal  when we do not see the end point we are looking  for. 
  You will NEVER see a return to health in a  patient whose genetics and epigenetics have  collided to give rise to Type II diabetes by  giving them a "pill". Giving any vitamin vs. a  placebo is sheer folly. However, incorporating  essential nutrients into a multi-tiered  protocol that CANNOT BE DOUBLE-BLINDED (sorry  folks) will ultimately net the effect you are  looking for - improved symptoms, a decreased  need for pharmaceutical glucose control, weight  loss, improved sleep, more even temperament  with less anxiety, resolution or improvement in  other pathology, etc. 
  Does it really make sense to give an overweight  diabetic who largely depends on their  medication to control their A1C level a vitamin  pill and expect to see any real improvement in  the health of the patient. How many patients  walk into your office with normal A1C levels  but have painful neuropathy and/or numbness?  Ladies and gentlemen, we are not treating blood  tests. If we continue to pour water on the  smoke, we will continue to battle the  diabetes/diabesity syndrome that is wreaking  havoc on our population. 
  I haven't had the ability, after 30 years of  being a spokesperson for functional medicine in  podiatry, to have even a small effect on the  paradigm that 99.9% of our nation's podiatrists  are employing daily in their practice. For  that, I'll say shame on me. But the reality is,  if you all continue to believe that "evidence- based medicine" will have any real effect on  stemming the tide of pathology in this country,  all I can say is shame on you.
  Robert Kornfeld, DPM, NY, NY
  
  
 
 There are no more messages in this thread. 
 | 
 
|   | 
 
 
 |  
 
 |